SCHEMBL22258682

SCHEMBL22258682

Clc1nc(Cl)c2ccc3sc4ccc5ccccc5c4c3c2n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.37
CYP3A4 P08684 2/20 0.37
MAPK1 P28482 2/20 0.37
LMNA P02545 1/20 0.37
APEX1 P27695 1/20 0.37
PMP22 Q01453 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.35
RAB9A P51151 2/20 0.33
TSHR P16473 2/20 0.33
HSD17B10 Q99714 2/20 0.33
NPC1 O15118 1/20 0.33
HPRT1 P00492 1/20 0.33
HPGD P15428 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
ATM Q13315 1/20 0.33
HIF1A Q16665 1/20 0.33
CYP1A1 P04798 4/20 0.33
CYP1B1 Q16678 4/20 0.33
CYP1A2 P05177 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22258707 0.88 CYP1A1 (0.38) MAPTCYP3A4MAPK1LMNAAPEX1
SCHEMBL19758769 0.85 GPR3 (0.39) MAPTCYP3A4RAB9ANPC1HPGD
SCHEMBL22258684 0.83 LMNA (0.41) MAPTCYP3A4MAPK1LMNAAPEX1
SCHEMBL22258720 0.82 CYP1A1 (0.34) MAPTCYP3A4MAPK1LMNAAPEX1
SCHEMBL22258321 0.81
SCHEMBL18853714 0.81 MAPT (0.35) MAPTCYP3A4MAPK1LMNAAPEX1
SCHEMBL22258685 0.80 CYP1A1 (0.36) MAPTLMNAL3MBTL1RAB9ANPC1
SCHEMBL30184670 0.79 MAPT (0.51) MAPTCYP3A4MAPK1LMNAAPEX1
SCHEMBL18688165 0.79 MAPT (0.51) MAPTCYP3A4MAPK1LMNAAPEX1
SCHEMBL30062535 0.77 HSD17B10 (0.52) CYP3A4MAPK1L3MBTL1RAB9ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11211568-B2 Compound for organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2021-12-28 US disclosed
US-20200235311-A1 COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11211568-B2 Compound for organic electroluminescence device using the same OR10J3, PIEZO1, ICMT MAPT 686/4885CYP3A4 417/4885MAPK1 3526/4885
US-20200235311-A1 COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME OR10J3, PIEZO1, ICMT MAPT 686/4885CYP3A4 417/4885MAPK1 3526/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.